Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 2 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

2
Player Avatar rh109605 (< 20) Submitted: 2/14/2007 2:00:17 PM : Outperform Start Price: $9.90 ALXN Score: +1,523.26

I believe that this company's new cancer drug will draw in many investors over the next few months and the drug itself, which is in FDA review, looks like a definite winner. I suspect this stock to hit $65 , maybe as high as $80 by Q4 07.

Report this Post 3 Replies
Member Avatar star60629 (74.00) Submitted: 4/27/2007 3:27:49 PM
Recs: 0

And what if this cancer drug is not successful. This co is projected to lose $3.96 a share this year.If they dont start making money they will need to float more shares.$80 yeah sure. Take a few of these hyped up biotechs losing big money and practically no book value you will find it easy to beat the s&p. Its a crapshoot as to winning with this stock.

Member Avatar YoHo00 (< 20) Submitted: 10/4/2007 1:40:17 PM
Recs: 0

Drug was approved in March in the US and in June for Europe. First quarter of sales was expected to be $3mm and it turn out to be $9.8mm. This quarter sales are expected to be $15mm and we will learn in the end of October if they beat again. Right now with the stock at $69/sh it looks like the call of $80/sh by the 4Q07 looks like the right one...

Member Avatar zzlangerhans (99.68) Submitted: 7/28/2008 2:57:26 PM
Recs: 0

You nailed this one. Kudos. I'm still amazed the street keeps propping this up. I wish I could put my red thumb on now instead of last year.

Featured Broker Partners


Advertisement